DnB Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$108M Sell
897,124
-53,210
-6% -$6.14M 0.38% 47
2025
Q4
$100M Buy
950,334
+201,907
+27% +$19M 0.35% 46
2025
Q3
$62.8M Sell
748,427
-5,667
-0.8% -$467K 0.23% 67
2025
Q2
$59.7M Sell
754,094
-3,000
-0.4% -$238K 0.25% 65
2025
Q1
$68M Sell
757,094
-20,190
-3% -$1.89M 0.31% 61
2024
Q4
$77.3M Buy
777,284
+54,013
+7% +$5.57M 0.33% 47
2024
Q3
$82.1M Buy
723,271
+41,716
+6% +$4.96M 0.37% 49
2024
Q2
$84.4M Buy
681,555
+35,130
+5% +$4.53M 0.4% 43
2024
Q1
$85.3M Sell
646,425
-83,339
-11% -$10.3M 0.44% 40
2023
Q4
$79.6M Buy
729,764
+9,432
+1% +$979K 0.41% 45
2023
Q3
$74.2M Buy
720,332
+36,108
+5% +$3.89M 0.44% 43
2023
Q2
$79M Buy
684,224
+78,804
+13% +$8.95M 0.45% 48
2023
Q1
$64.4M Sell
605,420
-58,977
-9% -$6.37M 0.41% 51
2022
Q4
$73.7M Buy
664,397
+10,322
+2% +$1.06M 0.52% 39
2022
Q3
$56.3M Sell
654,075
-3,203
-0.5% -$286K 0.43% 49
2022
Q2
$59.9M Sell
657,278
-20,716
-3% -$1.84M 0.42% 56
2022
Q1
$55.6M Buy
677,994
+25,402
+4% +$2M 0.33% 64
2021
Q4
$50M Buy
652,592
+160
+0% +$12.7K 0.29% 69
2021
Q3
$49M Buy
652,432
+26,359
+4% +$2M 0.32% 62
2021
Q2
$48.7M Buy
626,073
+59,674
+11% +$4.44M 0.32% 57
2021
Q1
$41.7M Buy
566,399
+43,096
+8% +$3.18M 0.3% 58
2020
Q4
$40.8M Sell
523,303
-55,243
-10% -$4.23M 0.36% 52
2020
Q3
$45.8M Buy
578,546
+12,271
+2% +$961K 0.49% 38
2020
Q2
$41.8M Buy
566,275
+84,255
+17% +$6.34M 0.49% 41
2020
Q1
$35.4M Sell
482,020
-70,511
-13% -$5.54M 0.52% 38
2019
Q4
$48M Sell
552,531
-57,034
-9% -$4.68M 0.47% 43
2019
Q3
$49M Sell
609,565
-85,907
-12% -$6.88M 0.55% 39
2019
Q2
$55.6M Buy
695,472
+35,318
+5% +$2.7M 0.64% 33
2019
Q1
$52.4M Buy
660,154
+12,295
+2% +$920K 0.6% 37
2018
Q4
$47.2M Buy
647,859
+57,557
+10% +$4.06M 0.61% 37
2018
Q3
$40M Buy
590,302
+63,809
+12% +$4.07M 0.45% 48
2018
Q2
$30.5M Buy
526,493
+7,441
+1% +$420K 0.36% 57
2018
Q1
$27M Sell
519,052
-46,322
-8% -$2.5M 0.32% 67
2017
Q4
$30.4M Buy
565,374
+270,007
+91% +$15M 0.37% 59
2017
Q3
$18M Sell
295,367
-184,796
-38% -$11.2M 0.24% 81
2017
Q2
$29.4M Sell
480,163
-49,151
-9% -$2.99M 0.43% 56
2017
Q1
$32.1M Buy
529,314
+76,399
+17% +$4.64M 0.5% 47
2016
Q4
$25.4M Sell
452,915
-36,575
-7% -$2.14M 0.47% 50
2016
Q3
$29.1M Buy
489,490
+81,744
+20% +$4.78M 0.57% 41
2016
Q2
$22.4M Sell
407,746
-58,269
-13% -$3.1M 0.48% 55
2016
Q1
$23.5M Sell
466,015
-129,847
-22% -$6.36M 0.49% 51
2015
Q4
$30M Buy
595,862
+258,960
+77% +$13.1M 0.64% 40
2015
Q3
$15.9M Buy
336,902
+18,864
+6% +$1M 0.4% 61
2015
Q2
$17.3M Buy
318,038
+2,306
+0.7% +$129K 0.38% 61
2015
Q1
$17.3M Buy
315,732
+121,673
+63% +$6.89M 0.39% 62
2014
Q4
$10.5M Buy
194,059
+18,235
+10% +$1.02M 0.24% 85
2014
Q3
$9.95M Buy
175,824
+10,375
+6% +$583K 0.22% 85
2014
Q2
$9.13M Buy
+165,449
New +$9.03M 0.19% 95
2013
Q4
$6.54M Sell
136,982
-16,268
-11% -$744K 0.15% 108
2013
Q3
$6.96M Buy
153,250
+3,144
+2% +$144K 0.19% 85
2013
Q2
$6.65M Buy
+150,106
New +$6.7M 0.2% 74

Other funds holding MRK

DnB Asset Management's MRK Position: Q1 2026 in Review

DnB Asset Management reduced its Merck (MRK) stake by 5.6% in Q1 2026, selling an estimated $6.14M and leaving 897,124 shares worth $108M. The position accounts for 0.38% of the portfolio, ranked #47.

DnB Asset Management first reported a position in MRK in Q2 2013 and has held it in 51 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • DnB Asset Management held 897,124 shares of Merck worth $108M as of Q1 2026.
  • DnB Asset Management sold 53,210 Merck shares in Q1 2026, an estimated $6.14M.
  • Merck made up 0.38% of DnB Asset Management's portfolio in Q1 2026, its #47 holding.
  • DnB Asset Management first reported a position in Merck in Q2 2013 and has held it in 51 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on DnB Asset Management's 13F filing for Q1 2026, filed 14 May 2026.